论文部分内容阅读
目的:探讨阿奇霉素联合痰清热注射液治疗支原体肺炎的临床疗效。方法:选取支原体肺炎住院患儿96例为研究对象,将96例患儿根据住院先后顺序分为观察组和对照组,每组48例。对照组患儿均首先接受化痰止咳、退热等对症治疗,并给予阿奇霉素;观察组在对照组治疗基础之上加用痰热清注射液,治疗后观察两组患儿的临床疗效。结果:观察组总有效率为95.8%,对照组总有效率为72.9%,观察组明显高于对照组(P<0.05);观察组患儿的临床症状体征的平均消失时间均显著短于对对照组(P<0.05);观察组1例出现恶心呕吐腹泻,对照组5例发生不良反应。结论:阿奇霉素联合痰清热注射液治疗支原体肺炎临床疗效显著,并发症发生率低。
Objective: To investigate the clinical effect of azithromycin combined with phlegm and heat injection in the treatment of mycoplasma pneumonia. Methods: A total of 96 children hospitalized with mycoplasma pneumonia were selected as study objects. 96 children were divided into observation group and control group according to the order of hospitalization, 48 cases in each group. The control group of children were first received symptomatic treatment of phlegm and cough, fever and other azithromycin; observation group in the control group based on the treatment with Tanreqing injection, after treatment, the clinical efficacy of both groups were observed. Results: The total effective rate was 95.8% in the observation group and 72.9% in the control group, which was significantly higher in the observation group than in the control group (P <0.05). The mean disappearance time of clinical symptoms and signs in the observation group was significantly shorter than that in the control group Control group (P <0.05). One patient in the observation group had nausea and vomiting diarrhea, and five patients in the control group had adverse reactions. Conclusion: Azithromycin combined with phlegm and heat injection for the treatment of mycoplasma pneumonia clinical significant effect, the incidence of complications is low.